Page last updated: 2024-11-01

niclosamide and Koch's Disease

niclosamide has been researched along with Koch's Disease in 2 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Le, NH1
Constant, P1
Tranier, S1
Nahoum, V1
Guillet, V1
Maveyraud, L1
Daffé, M1
Mourey, L1
Verhaeghe, P1
Marrakchi, H1
Fan, X1
Xu, J1
Files, M1
Cirillo, JD1
Endsley, JJ1
Zhou, J1
Endsley, MA1

Other Studies

2 other studies available for niclosamide and Koch's Disease

ArticleYear
Drug screening approach against mycobacterial fatty acyl-AMP ligase FAAL32 renews the interest of the salicylanilide pharmacophore in the fight against tuberculosis.
    Bioorganic & medicinal chemistry, 2022, 10-01, Volume: 71

    Topics: Adenosine Monophosphate; Antitubercular Agents; Drug Evaluation, Preclinical; Humans; Mycobacterium

2022
Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing).
    Tuberculosis (Edinburgh, Scotland), 2019, Volume: 116S

    Topics: Anti-HIV Agents; Antitubercular Agents; Coinfection; HIV-1; Humans; Jurkat Cells; Macrophages; Mycob

2019